These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23545295)

  • 21. Activation of NF-κB signaling by the dense granule protein GRA15 of a newly isolated type 1 Toxoplasma gondii strain.
    Guo G; Cui J; Song L; Tang L; Fan S; Shen B; Fang R; Hu M; Zhao J; Zhou Y
    Parasit Vectors; 2022 Sep; 15(1):347. PubMed ID: 36175964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TgROP18 targets IL20RB for host-defense-related-STAT3 activation during Toxoplasma gondii infection.
    Kong L; Jiang D; He C; Xia J; Wei H; Zhou L; Peng H
    Parasit Vectors; 2020 Aug; 13(1):400. PubMed ID: 32767999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hammondia hammondi harbors functional orthologs of the host-modulating effectors GRA15 and ROP16 but is distinguished from Toxoplasma gondii by a unique transcriptional profile.
    Walzer KA; Wier GM; Dam RA; Srinivasan AR; Borges AL; English ED; Herrmann DC; Schares G; Dubey JP; Boyle JP
    Eukaryot Cell; 2014 Dec; 13(12):1507-18. PubMed ID: 25280815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice.
    Yuan ZG; Zhang XX; He XH; Petersen E; Zhou DH; He Y; Lin RQ; Li XZ; Chen XL; Shi XR; Zhong XL; Zhang B; Zhu XQ
    Clin Vaccine Immunol; 2011 Jan; 18(1):119-24. PubMed ID: 21106780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Toxoplasma gondii virulence factor ROP16 acts in cis and trans, and suppresses T cell responses.
    Chen L; Christian DA; Kochanowsky JA; Phan AT; Clark JT; Wang S; Berry C; Oh J; Chen X; Roos DS; Beiting DP; Koshy AA; Hunter CA
    J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31961916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The
    Thind AC; Mota CM; Gonçalves APN; Sha J; Wohlschlegel JA; Mineo TWP; Bradley PJ
    mSphere; 2023 Oct; 8(5):e0026323. PubMed ID: 37768053
    [No Abstract]   [Full Text] [Related]  

  • 27. Toxoplasma gondii triggers phosphorylation and nuclear translocation of dendritic cell STAT1 while simultaneously blocking IFNγ-induced STAT1 transcriptional activity.
    Schneider AG; Abi Abdallah DS; Butcher BA; Denkers EY
    PLoS One; 2013; 8(3):e60215. PubMed ID: 23527309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rhoptry and Dense Granule Secreted Effectors Regulate CD8
    Rommereim LM; Fox BA; Butler KL; Cantillana V; Taylor GA; Bzik DJ
    Front Immunol; 2019; 10():2104. PubMed ID: 31555296
    [No Abstract]   [Full Text] [Related]  

  • 29. Type I ROP16 regulates retinal inflammatory responses during ocular toxoplasmosis.
    Rochet E; Argy N; Greigert V; Brunet J; Sabou M; Marcellin L; de-la-Torre A; Sauer A; Candolfi E; Pfaff AW
    PLoS One; 2019; 14(3):e0214310. PubMed ID: 30901349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxoplasma type II effector GRA15 has limited influence in vivo.
    Merritt EF; Kochanowsky JA; Hervé P; Watson AA; Koshy AA
    PLoS One; 2024; 19(3):e0300764. PubMed ID: 38551902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3.
    Yamamoto M; Standley DM; Takashima S; Saiga H; Okuyama M; Kayama H; Kubo E; Ito H; Takaura M; Matsuda T; Soldati-Favre D; Takeda K
    J Exp Med; 2009 Nov; 206(12):2747-60. PubMed ID: 19901082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anticancer mechanisms of
    Li G; Li Q; Tong Y; Zeng J; Dang T; Yang N; Zhou Y; Ma L; Ge Q; Zhao Z
    Cancer Biol Ther; 2024 Dec; 25(1):2392902. PubMed ID: 39174877
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Bando H; Lee Y; Sakaguchi N; Pradipta A; Sakamoto R; Tanaka S; Ma JS; Sasai M; Yamamoto M
    Front Cell Infect Microbiol; 2019; 9():140. PubMed ID: 31119110
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of Two Major
    Hernández-de-Los-Ríos A; Murillo-Leon M; Mantilla-Muriel LE; Arenas AF; Vargas-Montes M; Cardona N; de-la-Torre A; Sepúlveda-Arias JC; Gómez-Marín JE
    Front Cell Infect Microbiol; 2019; 9():413. PubMed ID: 31867288
    [No Abstract]   [Full Text] [Related]  

  • 35. Inducible Nitric Oxide Synthase Is a Key Host Factor for
    Bando H; Lee Y; Sakaguchi N; Pradipta A; Ma JS; Tanaka S; Cai Y; Liu J; Shen J; Nishikawa Y; Sasai M; Yamamoto M
    mBio; 2018 Oct; 9(5):. PubMed ID: 30301855
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Xu YW; Xing RX; Zhang WH; Li L; Wu Y; Hu J; Wang C; Luo QL; Shen JL; Chen X
    World J Gastroenterol; 2019 Dec; 25(45):6634-6652. PubMed ID: 31832003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective and strain-specific NFAT4 activation by the Toxoplasma gondii polymorphic dense granule protein GRA6.
    Ma JS; Sasai M; Ohshima J; Lee Y; Bando H; Takeda K; Yamamoto M
    J Exp Med; 2014 Sep; 211(10):2013-32. PubMed ID: 25225460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival.
    Tuladhar S; Kochanowsky JA; Bhaskara A; Ghotmi Y; Chandrasekaran S; Koshy AA
    PLoS Pathog; 2019 Oct; 15(10):e1007856. PubMed ID: 31648279
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Ihara F; Fereig RM; Himori Y; Kameyama K; Umeda K; Tanaka S; Ikeda R; Yamamoto M; Nishikawa Y
    Front Immunol; 2020; 11():1709. PubMed ID: 32849602
    [No Abstract]   [Full Text] [Related]  

  • 40. Strain- and Dose-Dependent Reduction of
    Jennes M; De Craeye S; Devriendt B; Dierick K; Dorny P; Cox E
    Front Cell Infect Microbiol; 2017; 7():232. PubMed ID: 28642841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.